Blood-based multi-cancer detection using a novel variant calling assay (DEEPGENTM): early clinical results
ContributorsRis, Frédéric; Hellan, Minia; Douissard, Jonathan; Nieva, Jorge J; Triponez, Frédéric; Woo, Yanghee; Geller, David; Buchs, Nicolas; Buehler, Leo Hans; Moenig, Stefan Paul; Iselin, Christophe; Karenovics, Wolfram; Petignat, Patrick; Lam, Giang Thanh; Undurraga Malinverno, Manuela Stefania; Tuttle, Rebecca; Ouellette, James; Bose, Debashish; Ismail, Nael; Toso, Christian
Published inCancers, vol. 13, no. 16, 4104
Publication date2021
Abstract
Keywords
- DEEPGENTM
- Cancer detection
- Cancer screening
- Cell-free DNA
- Early detection
- Liquid biopsy
- Machine-learning
Affiliation
Citation (ISO format)
RIS, Frédéric et al. Blood-based multi-cancer detection using a novel variant calling assay (DEEPGENTM): early clinical results. In: Cancers, 2021, vol. 13, n° 16, p. 4104. doi: 10.3390/cancers13164104
Main files (1)
Article (Published version)
Identifiers
- PID : unige:156762
- DOI : 10.3390/cancers13164104
- PMID : 34439258
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392437/
ISSN of the journal2072-6694